Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 275279, 13 pages
http://dx.doi.org/10.1155/2013/275279
Review Article

Trends in the Treatment of Hypertension from the Perspective of Traditional Chinese Medicine

1Department of Cardiology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beixiange NO. 5, Xicheng District, Beijing 100053, China
2Department of Cardiology, Traditional Chinese Medicine Hospital of Beijing, Beijing 100010, China
3Department of Endocrinology, Traditional Chinese Medicine Hospital of Mentougou District, Beijing 102300, China

Received 9 October 2012; Revised 3 June 2013; Accepted 10 June 2013

Academic Editor: Keji Chen

Copyright © 2013 Xingjiang Xiong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Sliwa, S. Stewart, and B. J. Gersh, “Hypertension: a global perspective,” Circulation, vol. 123, no. 24, pp. 2892–2896, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Redwood, “Hypertension, society, and public policy,” European Heart Journal, vol. 9, pp. B13–B18, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. K. J. Chen, K. K. Hui, M. S. Lee, and H. Xu, “The potential benefit of complementary/alternative medicine in cardiovascular diseases,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 125029, 1 pages, 2012. View at Publisher · View at Google Scholar
  4. G. Y. Yeh, R. B. Davis, and R. S. Phillips, “Use of complementary therapies in patients with cardiovascular disease,” American Journal of Cardiology, vol. 98, no. 5, pp. 673–680, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Ernst, “Complementary/alternative medicine for hypertension: a mini-review,” Wiener Medizinische Wochenschrift, vol. 155, no. 17-18, pp. 386–391, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Nahas, “Complementary and alternative medicine approaches to blood pressure reduction: an evidence-based review,” Canadian Family Physician, vol. 54, no. 11, pp. 1529–1533, 2008. View at Google Scholar · View at Scopus
  7. H. Xu and K. Chen, “Integrating traditional medicine with biomedicine towards a patient-centered healthcare system,” Chinese Journal of Integrative Medicine, vol. 17, no. 2, pp. 83–84, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Wang and X. J. Xiong, “Evidence-based Chinese medicine for hypertension,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 978398, 12 pages, 2013. View at Publisher · View at Google Scholar
  9. H. W. Zhang, J. Tong, G. Zhou, H. Jia, and Y. Jiang, “Tianma gouteng yin formula for treating primary hypertension,” Cochrane Database of Systematic Reviews, no. 6, Article ID CD008166, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. P. M. Stavro, M. Woo, T. F. Heim, L. A. Leiter, and V. Vuksan, “North American ginseng exerts a neutral effect on blood pressure in individuals with hypertension,” Hypertension, vol. 46, no. 2, pp. 406–411, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. P. M. Stavro, M. Woo, L. A. Leiter, T. F. Heim, J. L. Sievenpiper, and V. Vuksan, “Long-term intake of North American ginseng has no effect on 24-hour blood pressure and renal function,” Hypertension, vol. 47, no. 4, pp. 791–796, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. J. J. Li, Z. L. Lu, W. R. Kou et al., “Long-term effects of xuezhikang on blood pressure in hypertensive patients with previous myocardial infarction: data from the Chinese coronary secondary prevention study (CCSPS),” Clinical and Experimental Hypertension, vol. 32, no. 8, pp. 491–498, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. J. J. Li, Z. L. Lu, W. R. Kou et al., “Impact of Xuezhikang on coronary events in hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS),” Annals of Medicine, vol. 42, no. 3, pp. 231–240, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. J. S. Janicki and S. P. Levick, “The convergence of ancient chinese medicine with modern therapeutics to prevent cardiac fibrosis,” American Journal of Hypertension, vol. 25, no. 2, p. 139, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Wang, B. Feng, and X. J. Xiong, “Chinese herbal medicine for the treatment of obesity-related hypertension: a systematic review of randomized controlled trials,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 757540, 11 pages, 2013. View at Publisher · View at Google Scholar
  16. X. J. Xiong, X. C. Yang, Y. M. Liu, Y. Zhang, P. Q. Wang, and J. Wang, “Chinese herbal formulas for treating hypertension in traditional Chinese medicine: perspective of modern science,” Hypertension Research, 2013. View at Publisher · View at Google Scholar
  17. J. Wang, P. Q. Wang, and X. J. Xiong, “Current situation and re-understanding of syndrome and formula syndrome in Chinese medicine,” Internal Medicine, 2012. View at Publisher · View at Google Scholar
  18. K. J. Chen and L. Li, “Study of traditional Chinese medicine—which is after all the right way?” Chinese Journal of Integrative Medicine, vol. 11, no. 4, pp. 241–242, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Cheung, “TCM: made in China,” Nature, vol. 480, supplement 7378, pp. S82–S83, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Tian, “Where West meets East,” Nature, vol. 480, supplement 7378, pp. S84–S86, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. K. J. Chen, “Clinical service of Chinese medicine,” Chinese Journal of Integrative Medicine, vol. 14, no. 3, pp. 163–164, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Liu, “The clinical trial barriers,” Nature, vol. 480, supplement 7378, p. S100, 2011. View at Publisher · View at Google Scholar
  23. G. Dobos and I. Tao, “The model of Western integrative medicine: the role of Chinese medicine,” Chinese Journal of Integrative Medicine, vol. 17, no. 1, pp. 11–20, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. X. Xiong, F. Chu, H. Li, and Q. He, “Clinical application of the TCM classic formulae for treating chronic bronchitis,” Journal of Traditional Chinese Medicine, vol. 31, no. 1, pp. 69–72, 2011. View at Google Scholar · View at Scopus
  25. J. Wang and X. J. Xiong, “Current situation and perspectives of clinical study in integrative medicine in China,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 268542, 11 pages, 2012. View at Publisher · View at Google Scholar
  26. K. J. Chen and H. Xu, “The integration of traditional Chinese medicine and Western medicine,” European Review, vol. 11, no. 2, pp. 225–235, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. Q. H. Shang, H. Xu, X. Y. Lu, C. Wen, D. Shi, and K. Chen, “A multi-center randomized double-blind placebo-controlled trial of Xiongshao Capsule in preventing restenosis after percutaneous coronary intervention: a subgroup analysis of senile patients,” Chinese Journal of Integrative Medicine, vol. 17, no. 9, pp. 669–674, 2011. View at Google Scholar · View at Scopus
  28. F. Y. Chu, J. Wang, K. W. Yao, and Z. Z. Li, “Effect of Xuefu Zhuyu Capsule on the symptoms and signs and health-related quality of life in the unstable angina patients with blood-stasis syndrome after percutaneous coronary intervention: a randomized controlled trial,” Chinese Journal of Integrative Medicine, vol. 16, no. 5, pp. 399–405, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. Z. Y. Tang and J. Wang, “Fighting against acquired immunodeficiency syndrome with Chinese medicine: a perspective from China,” Chinese Journal of Integrative Medicine, vol. 17, no. 5, pp. 323–324, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. B. S. Li, Z. H. Li, X. D. Tang et al., “A randomized, controlled, double-blinded and double-dummy trial of the effect of Tongjiang Granule on the nonerosive reflux disease of and Gan-Wei incoordination syndrome,” Chinese Journal of Integrative Medicine, vol. 17, no. 5, pp. 339–345, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Zhang, M. Jiang, and A. Lu, “A traditional Chinese medicine versus Western combination therapy in the treatment of rheumatoid arthritis: two-stage study protocol for a randomized controlled trial,” Trials, vol. 12, p. 137, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. X. Deng, J. Liang, F. S. Wu, Y. B. Li, Y. P. Zhang, and Y. F. Tang, “Influence of Fuzheng Huayu Tablet on mental state and social function of patients with post-hepatitis B liver cirrhosis,” Chinese Journal of Integrative Medicine, vol. 18, no. 6, pp. 466–472, 2012. View at Publisher · View at Google Scholar
  33. P. Liu, “Fuzheng Huayu Capsule in the treatment of liver fibrosis: clinical evidence and mechanism of action,” Chinese Journal of Integrative Medicine, vol. 18, no. 5, pp. 398–400, 2012. View at Publisher · View at Google Scholar
  34. X. G. Feng, W. J. Hao, Z. Ding, Q. Sui, H. Guo, and J. Fu, “Clinical Study on Tongyan Spray for post-stroke dysphagia patients: a randomized controlled trial,” Chinese Journal of Integrative Medicine, vol. 18, no. 5, pp. 345–349, 2012. View at Publisher · View at Google Scholar
  35. C. Shou, J. Li, and Z. Liu, “Complementary and alternative medicine in the treatment of menopausal symptoms,” Chinese journal of integrative medicine, vol. 17, no. 12, pp. 883–888, 2011. View at Google Scholar · View at Scopus
  36. C. J. Lu, Y. Xiang, X. L. Xie, M. L. Xuan, and Z. H. He, “A randomized controlled single-blind clinical trial on 84 outpatients with psoriasis vulgaris by auricular therapy combined with optimized Yinxieling Formula,” Chinese Journal of Integrative Medicine, vol. 18, no. 3, pp. 186–191, 2012. View at Publisher · View at Google Scholar
  37. G. W. Zhong, M. J. Chen, Y. h. Luo et al., “Effect of Chinese herbal medicine for calming Gan and suppressing hyperactive yang on arterial elasticity function and circadian rhythm of blood pressure in patients with essential hypertension,” Chinese Journal of Integrative Medicine, vol. 17, no. 6, pp. 414–420, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Benetos, P. Salvi, and P. Lacolley, “Blood pressure regulation during the aging process: the end of the “hypertension era”?” Journal of Hypertension, vol. 29, no. 4, pp. 646–652, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. K. Yin and C. K. Tang, “Inflammation, lipid metabolism dysfunction, and hypertension: active research fields in atherosclerosis-related cardiovascular disease in China,” Science China Life Sciences, vol. 54, no. 10, pp. 976–979, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. R. E. Katholi and D. M. Couri, “Left ventricular hypertrophy: major risk factor in patients with hypertension: update and practical clinical applications,” International Journal of Hypertension, vol. 2011, Article ID 495349, 10 pages, 2011. View at Publisher · View at Google Scholar
  41. H. Li, L. Liu, W. Zhao et al., “Effect of traditional and integrative regimens on quality of life and early renal impairment in elderly patients with isolated systolic hypertension,” Chinese Journal of Integrative Medicine, vol. 16, no. 3, pp. 216–221, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. H. Xu and K. Chen, “Integrative medicine: the experience from China,” Journal of Alternative and Complementary Medicine, vol. 14, no. 1, pp. 3–7, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. K. J. Chen, “Where are we going?” Chinese Journal of Integrative Medicine, vol. 16, no. 2, pp. 100–101, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. G. Mancia, G. De Backer, A. Dominiczak et al., “Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC),” Journal of Hypertension, vol. 25, no. 6, pp. 1105–1187, 2007. View at Publisher · View at Google Scholar
  45. X. J. Xiong and J. Wang, “Application of classic formulae in treatment of hypertension,” Zhongguo Zhong Yao Za Zhi, vol. 38, no. 11, pp. 27–31, 2013. View at Google Scholar
  46. W. Liu, X. J. Xiong, and J. Wang, “Clinical application of therapy eliminating tuibidity and calming liver in the treatment of essential hypertension with metabolic disorders,” Zhongguo Zhong Yao Za Zhi, vol. 38, no. 8, pp. 1251–1254, 2013. View at Google Scholar
  47. X. J. Xiong, X. C. Yang, B. Feng et al., “Zhen gan xi feng decoction, a traditional Chinese herbal formula, for the treatment of essential hypertension: a systematic review of randomized controlled trials,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 982380, 9 pages, 2013. View at Publisher · View at Google Scholar
  48. A. B. Luiz, I. Cordovil, J. B. Filho, and A. S. Ferreira, “Zangfu zheng (patterns) are associated with clinical manifestations of zang shang (target-organ damage) in arterial hypertension,” Chinese Medicine, vol. 6, p. 23, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. W. L. Gu, Z. X. Shi, Y. X. Yu, Y. Wu, B. Lu, and K. Hui, “Distribution characteristics of syndrome types in essential hypertension,” Journal of Chinese Integrative Medicine, vol. 8, no. 9, pp. 842–847, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. H. Xu and K. J. Chen, “Progress, difficulty and countermeasure in treating hypertensive disease with integrated Chinese and western medicine,” Shi Jie Zhong Yi Yao, vol. 2, no. 1, pp. 3–5, 2007. View at Google Scholar
  51. J. Wang and X. J. Xiong, “Control strategy on hypertension in Chinese medicine,” Evidence-based Complementary and Alternative Medicine, vol. 2012, Article ID 284847, 6 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. W. Gu, Y. Cao, Z. Shi, and K. Hui, “Potential of using pattern diagnosis of traditional Chinese medicine to improve the clinical use of antihypertensive agents,” Journal of Chinese Integrative Medicine, vol. 5, no. 3, pp. 255–258, 2007. View at Google Scholar · View at Scopus
  53. H. A. Feldman, C. B. Johannes, C. A. Derby et al., “Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts Male Aging Study,” Preventive Medicine, vol. 30, no. 4, pp. 328–338, 2000. View at Publisher · View at Google Scholar · View at Scopus
  54. L. C. Keene and P. H. Davies, “Drug-related erectile dysfunction,” Adverse Drug Reactions and Toxicological Reviews, vol. 18, no. 1, pp. 5–24, 1999. View at Google Scholar · View at Scopus
  55. P. Buranakitjaroen, M. Phoojaroenchanachai, and S. Saravich, “Prevalence of erectile dysfunction among treated hypertensive males,” Journal of the Medical Association of Thailand, vol. 89, supplement 5, pp. S28–S36, 2006. View at Google Scholar · View at Scopus
  56. M. Baumhäkel, N. Schlimmer, and M. Böhm, “Effect of irbesartan on erectile function in patients with hypertension and metabolic syndrome,” International Journal of Impotence Research, vol. 20, no. 5, pp. 493–500, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. J. Wang, X. J. Xiong, and W. Liu, “Discussion on the treatment of hypertension by tonifying kidney,” Zhongguo Zhong Yao Za Zhi, vol. 38, no. 9, pp. 1277–1279, 2013. View at Google Scholar
  58. P. Anagnostis, A. Karagiannis, K. Tziomalos, V. G. Athyros, M. Kita, and D. P. Mikhailidis, “Endocrine hypertension: diagnosis and management of a complex clinical entity,” Current Vascular Pharmacology, vol. 8, no. 5, pp. 646–660, 2010. View at Google Scholar · View at Scopus
  59. K. Masuo, M. L. Tuck, and G. W. Lambert, “Hypertension and diabetes in obesity,” International Journal of Hypertension, vol. 2011, Article ID 695869, 2 pages, 2011. View at Publisher · View at Google Scholar
  60. B. H. Lee and T. M. Pan, “Benefit of Monascus-fermented products for hypertension prevention: a review,” Applied Microbiology and Biotechnology, vol. 49, no. 5, pp. 1151–1161, 2012. View at Publisher · View at Google Scholar · View at Scopus
  61. H. C. Shih, T. H. Lee, S. C. Chen, C. Li, and T. Shibuya, “Anti-hypertension effects of traditional Chinese medicine Ju-Ling-Tang on renal hypertensive rats,” American Journal of Chinese Medicine, vol. 33, no. 6, pp. 913–921, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. J. Talha, M. Priyanka, and A. Akanksha, “Hypertension and herbal plants,” International Research Journal of Pharmacy, vol. 2, no. 8, pp. 26–30, 2011. View at Google Scholar
  63. J. T. Cheng, “Review: drug therapy in Chinese traditional medicine,” Journal of Clinical Pharmacology, vol. 40, no. 5, pp. 445–450, 2000. View at Google Scholar · View at Scopus
  64. E. Chan, M. Tan, J. Xin, S. Sudarsanam, and D. E. Johnson, “Interactions between traditional Chinese medicines and Western therapeutics,” Current Opinion in Drug Discovery and Development, vol. 13, no. 1, pp. 50–65, 2010. View at Google Scholar · View at Scopus
  65. O. H. Lee, K. I. Kim, C. K. Han, Y. Kim, and H. Hong, “Effects of acidic polysaccharides from Gastrodia rhizome on systolic blood pressure and serum lipid concentrations in spontaneously hypertensive rats fed a high-fat diet,” International Journal of Molecular Sciences, vol. 13, no. 1, pp. 698–709, 2012. View at Publisher · View at Google Scholar · View at Scopus
  66. J. Y. Zhou and S. W. Zhou, “Antihypertensive and neuroprotective activities of rhynchophylline: the role of rhynchophylline in neurotransmission and ion channel activity,” Journal of Ethnopharmacology, vol. 132, no. 1, pp. 15–27, 2010. View at Publisher · View at Google Scholar · View at Scopus
  67. S. H. Chen, G. Y. Lv, X. D. Zhang et al., “Anti-hypertensive effects of laiju extract in two different rat models,” Asia Pacific Journal of Clinical Nutrition, vol. 16, no. 1, pp. 309–312, 2007. View at Google Scholar · View at Scopus
  68. J. P. Wang, J. L. Ruan, Y. L. Cai, and Y. X. Wu, “Antiinflammatory and analgesic activity of topical administration of Siegesbeckia pubescens,” Pakistan Journal of Pharmaceutical Sciences, vol. 21, no. 2, pp. 89–91, 2008. View at Google Scholar · View at Scopus
  69. O. A. Phillips, K. T. Mathew, and M. A. Oriowo, “Antihypertensive and vasodilator effects of methanolic and aqueous extracts of Tribulus terrestris in rats,” Journal of Ethnopharmacology, vol. 104, no. 3, pp. 351–355, 2006. View at Publisher · View at Google Scholar · View at Scopus
  70. J. Gu, J. J. Wang, J. Yan et al., “Effects of lignans extracted from Eucommia ulmoides and aldose reductase inhibitor epalrestat on hypertensive vascular remodeling,” Journal of Ethnopharmacology, vol. 133, no. 1, pp. 6–13, 2011. View at Publisher · View at Google Scholar · View at Scopus
  71. L. Li, J. Yan, K. Hu et al., “Protective effects of Eucommia lignans against hypertensive renal injury by inhibiting expression of aldose reductase,” Journal of Ethnopharmacology, vol. 139, no. 2, pp. 454–461, 2012. View at Publisher · View at Google Scholar · View at Scopus
  72. F. Greenway, Z. Liu, Y. Yu, and A. Gupta, “A clinical trial testing the safety and efficacy of a standardized Eucommia ulmoides oliver bark extract to treat hypertension,” Alternative Medicine Review, vol. 16, no. 4, pp. 338–347, 2011. View at Google Scholar · View at Scopus
  73. M. Ouedraogo, M. Ruiz, E. Vardelle et al., “From the vasodilator and hypotensive effects of an extract fraction from Agelanthus dodoneifolius (DC) Danser (Loranthaceae) to the active compound dodoneine,” Journal of Ethnopharmacology, vol. 133, no. 2, pp. 345–352, 2011. View at Publisher · View at Google Scholar · View at Scopus
  74. M. Radenkovic, V. Ivetic, M. Popovic, S. Brankovic, and L. Gvozdenovic, “Effects of mistletoe (Viscum Album L., Loranthaceae) extracts on arterial blood pressure in rats treated with atropine sulfate and hexocycline,” Clinical and Experimental Hypertension, vol. 31, no. 1, pp. 11–19, 2009. View at Publisher · View at Google Scholar · View at Scopus
  75. R. L. Simeonova, V. B. Vitcheva, M. S. Kondeva-Burdina, I. N. Krasteva, S. D. Nikolov, and M. K. Mitcheva, “Effect of purified saponin mixture from Astragalus corniculatus on enzyme- and non-enzyme-induced lipid peroxidation in liver microsomes from spontaneously hypertensive rats and normotensive rats,” Phytomedicine, vol. 17, no. 5, pp. 346–349, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. B. Xue, J. Li, Q. Chai, Z. Liu, and L. Chen, “Effect of total flavonoid fraction of Astragalus complanatus R.Brown on angiotensin II-induced portal-vein contraction in hypertensive rats,” Phytomedicine, vol. 15, no. 9, pp. 759–762, 2008. View at Publisher · View at Google Scholar · View at Scopus
  77. L. M. Yao, T. W. Liu, W. F. Wu, and G. Q. Zhong, “Effects of Astragalus injection in reversing left ventricular hypertrophy induced by renal hypertension in rats,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 29, no. 10, pp. 918–921, 2009. View at Google Scholar
  78. Y. Z. Hou, G. R. Zhao, Y. J. Yuan, G. Zhu, and R. Hiltunen, “Inhibition of rat vascular smooth muscle cell proliferation by extract of Ligusticum chuanxiong and Angelica sinensis,” Journal of Ethnopharmacology, vol. 100, no. 1-2, pp. 140–144, 2005. View at Publisher · View at Google Scholar · View at Scopus
  79. N. B. Zhang, Z. G. Huang, W. D. Cui, and B. P. Ding, “Effects of puerarin on expression of cardiac Smad3 and Smad7 mRNA in spontaneously hypertensive rat,” Journal of Ethnopharmacology, vol. 138, no. 3, pp. 737–740, 2011. View at Publisher · View at Google Scholar · View at Scopus
  80. C. F. Ng, C. M. Koon, D. W. S. Cheung et al., “The anti-hypertensive effect of Danshen (Salvia miltiorrhiza) and Gegen (Pueraria lobata) formula in rats and its underlying mechanisms of vasorelaxation,” Journal of Ethnopharmacology, vol. 137, no. 3, pp. 1366–1372, 2011. View at Publisher · View at Google Scholar · View at Scopus
  81. D. D. Kim, F. A. Sánchez, R. G. Durán, T. Kanetaka, and W. N. Durán, “Endothelial nitric oxide synthase is a molecular vascular target for the Chinese herb Danshen in hypertension,” American Journal of Physiology, vol. 292, no. 5, pp. H2131–H2137, 2007. View at Publisher · View at Google Scholar · View at Scopus
  82. W. T. Chang, J. Dao, and Z. H. Shao, “Hawthorn: potential roles in cardiovascular disease,” American Journal of Chinese Medicine, vol. 33, no. 1, pp. 1–10, 2005. View at Publisher · View at Google Scholar · View at Scopus
  83. A. F. Walker, G. Marakis, A. P. Morris, and P. A. Robinson, “Promising hypotensive effect of hawthorn extract: a randomized double-blind pilot study of mild, essential hypertension,” Phytotherapy Research, vol. 16, no. 1, pp. 48–54, 2002. View at Publisher · View at Google Scholar · View at Scopus
  84. T. Sun, H. Xu, and F. Q. Xu, “Astragalus injection for hypertensive renal damage: a systematic review,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 929025, 6 pages, 2012. View at Publisher · View at Google Scholar
  85. J. Wang, B. Feng, X. C. Yang et al., “Tianma gouteng yin as adjunctive treatment for essential hypertension: a systematic review of randomized controlled trials,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 706125, 18 pages, 2013. View at Publisher · View at Google Scholar
  86. S. J. Wang, Y. Chen, D. D. He et al., “Inhibition of vascular smooth muscle cell proliferation by serum from rats treated orally with Gastrodia and Uncaria decoction, a traditional Chinese formulation,” Journal of Ethnopharmacology, vol. 114, no. 3, pp. 458–462, 2007. View at Publisher · View at Google Scholar · View at Scopus
  87. S. C. Ho, Y. F. Ho, T. H. Lai, T. Liu, S. Su, and R. Wu, “Effect of Tianma gouteng Decoction with subtractive ingredients and its active constituents on memory acquisition,” American Journal of Chinese Medicine, vol. 36, no. 3, pp. 593–602, 2008. View at Publisher · View at Google Scholar · View at Scopus
  88. S. X. Xian, S. Y. Hu, X. H. Liu, L. C. Zhao, and N. Y. Li, “Study on effect of Tianma gouteng decoction in intervening myocardial collagen reconstruction in renovascular hypertensive rats,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 23, no. 6, pp. 21–24, 2003. View at Google Scholar
  89. Z. W. Zhang, G. H. YUE, and Y. Luo, “Effects of Huanglian jie du decoction on prothrombotic state in spontaneous hypertension rats,” Zhongguo Shi Yan Fang Ji Xue Za Zhi, vol. 17, no. 2, pp. 105–108, 2011. View at Google Scholar
  90. Y. P. Han, N. S. Wang, S. Q. Mi, and Q. Liu, “Effect of Wuling Powder on rats with renal hypertension,” Zhong xi yi Jie he Xue Bao, vol. 1, no. 4, pp. 285–288, 2003. View at Google Scholar · View at Scopus
  91. J. Y. Chen, H. L. Fan, and S. F. Zhang, “Effect of modified Zexie decoction on prevention of kidney injuries of rats with hypertension induced by high-salt diet,” Zhong Yi Za Zhi, vol. 53, no. 3, pp. 234–237, 2012. View at Google Scholar
  92. X. J. Xiong, X. C. Yang, W. Liu et al., “Banxia baizhu tianma decoction for essential hypertension: a systematic review of randomized controlled trials,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 271462, 10 pages, 2012. View at Publisher · View at Google Scholar
  93. J. Y. Jiang, X. Z. Wang, S. S. Luo, X. Wang, K. Bian, and Y. Yan, “Effect of Banxia baizhu tianma decoction on the left ventricular hypertrophy of hypertrophied myocardium in spontaneously hypertensive rat,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 30, no. 10, pp. 1061–1066, 2010. View at Google Scholar
  94. Q. F. Wu, M. X. Wen, and D. H. Lan, “Effect of Banxia baizhu tianma decoction on insulin resistance and blood lipid in hypertensive patients with abundant phlegm-dampness syndrome,” Fujian Zhong Yi Xue Yuan Xue Bao, vol. 17, no. 2, pp. 8–10, 2007. View at Google Scholar
  95. Q. F. Wu, M. X. Wen, and D. H. Lan, “Effects of Banxia baizhu tianma decoction on salt sensitivity and blood lipid in hypertensive patients with abundant phlegm-dampness syndrome,” Fujian Yi Yao Za Zhi, vol. 29, no. 1, pp. 146–148, 2007. View at Google Scholar
  96. J. Wang, K. W. Yao, X. C. Yang et al., “Chinese patent medicine liu wei di huang wan combined with antihypertensive drugs, a new integrative medicine therapy, for the treatment of essential hypertension: a systematic review of randomized controlled trials,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 714805, 7 pages, 2012. View at Publisher · View at Google Scholar
  97. F. X. Huang, Y. Ye, P. Yan, and M. H. Chen, “Therapeutic observation of using Liuweidihuang Pills and pancreatic kininogenase interfering kidney damage by hypertensive disease,” Fujian Zhong Yi Xue Yuan Xue Bao, vol. 14, no. 5, pp. 9–11, 2004. View at Google Scholar
  98. L. L. Gao, B. C. Wang, and Q. Z. Lin, “Protective effect of Liuweidihuang pill combined with Shengmai capsule on heart of patients with hypertension,” Zhong Hua Zhong Yi Yao Za Zhi, vol. 28, no. 7, pp. 85–88, 2008. View at Google Scholar
  99. X. W. Li, “The effect of Shenqi Pill on the sexual function of young and middle-aged male hypertensive patients,” Zhejiang Zhong Xi Yi Jie He Za Zhi, vol. 18, no. 4, pp. 214–215, 2008. View at Google Scholar
  100. Y. L. Liu, “The effect of Golden Chamber Pill for Reinforcing Kidney qi combined with enalapril on urinary albumin in hypertensive patients,” Xin Zhong Yi, vol. 40, no. 8, pp. 37–38, 2008. View at Google Scholar
  101. National Pharmacopoeia Committee, Pharmacopoeia of People's Republic of China. Part 1, vol. 38 of Medicinal Materials and Decoction Pieces, China Medical Science Press, Beijing, China, 2010.
  102. Y. H. Xie, J. C. Zhang, Y. R. Jiang et al., “Data-mining of clinical hypertensive cases from Dr. Chen Keji,” Zhong Xi Yi Jie He Xin Nao Xue Guan Bing Za Zhi, vol. 6, no. 2, pp. 135–136, 2008. View at Google Scholar
  103. H. Xu and K. J. Chen, “Complementary and alternative medicine: is it possible to be mainstream?” Chinese Journal of Integrative Medicine, vol. 18, no. 6, pp. 403–404, 2012. View at Google Scholar
  104. A. Weil, “The state of the integrative medicine in the U.S. and Western World,” Chinese Journal of Integrative Medicine, vol. 17, no. 1, pp. 6–10, 2011. View at Publisher · View at Google Scholar · View at Scopus
  105. L. Jia, “Cancer complementary and alternative medicine research at the US National Cancer Institute,” Chinese Journal of Integrative Medicine, vol. 18, no. 5, pp. 325–332, 2012. View at Publisher · View at Google Scholar · View at Scopus
  106. J. J. Park, S. Beckman-Harned, G. Cho, D. Kim, and H. Kim, “The current acceptance, accessibility and recognition of Chinese and Ayurvedic medicine in the United States in the public, governmental, and industrial sectors,” Chinese Journal of Integrative Medicine, vol. 18, no. 6, pp. 405–408, 2012. View at Google Scholar
  107. H. Abolhassani, M. Naseri, and S. Mahmoudzadeh, “A survey of complementary and alternative medicine in Iran,” Chinese Journal of Integrative Medicine, vol. 18, no. 6, pp. 409–416, 2012. View at Publisher · View at Google Scholar
  108. J. M. Crow, “That healthy gut feeling,” Nature, vol. 480, supplement 7378, pp. S88–S89, 2011. View at Publisher · View at Google Scholar · View at Scopus
  109. M. Y. Liu and K. J. Chen, “Convergence: the tradition and the modern,” Chinese Journal of Integrative Medicine, vol. 18, no. 3, pp. 164–165, 2012. View at Google Scholar
  110. X. Sun, W. Wu, and Z. Lu, “Chinese integrative medicine: translation toward person-centered and balanced medicine,” Chinese Journal of Integrative Medicine, vol. 18, no. 1, pp. 3–6, 2012. View at Publisher · View at Google Scholar · View at Scopus
  111. N. Robinson, “Integrative medicine—traditional Chinese medicine, a model?” Chinese Journal of Integrative Medicine, vol. 17, no. 1, pp. 21–25, 2011. View at Publisher · View at Google Scholar · View at Scopus
  112. D. Eisenberg, “Reflections on the past and future of integrative medicine from a lifelong student of the integration of Chinese and Western medicine,” Chinese Journal of Integrative Medicine, vol. 17, no. 1, pp. 3–5, 2011. View at Publisher · View at Google Scholar · View at Scopus
  113. M. S. Lee, H. J. Lim, and M. S. Lee, “Impact of qigong exercise on self-efficacy and other cognitive perceptual variables in patients with essential hypertension,” Journal of Alternative and Complementary Medicine, vol. 10, no. 4, pp. 675–680, 2004. View at Publisher · View at Google Scholar · View at Scopus
  114. M. S. Lee, M. H. Pittler, R. Guo, and E. Ernst, “Qigong for hypertension: a systematic review of randomized clinical trials,” Journal of Hypertension, vol. 25, no. 8, pp. 1525–1532, 2007. View at Publisher · View at Google Scholar · View at Scopus
  115. J. I. Kim, J. Y. Choi, H. Lee, M. S. Lee, and E. Ernst, “Moxibustion for hypertension: a systematic review,” BMC Cardiovascular Disorders, vol. 10, p. 33, 2010. View at Publisher · View at Google Scholar · View at Scopus
  116. M. S. Lee, T. Choi, B. Shin, J. Kim, and S. Nam, “Cupping for hypertension: a systematic review,” Clinical and Experimental Hypertension, vol. 32, no. 7, pp. 423–425, 2010. View at Publisher · View at Google Scholar · View at Scopus
  117. D. D. Kim, F. A. Sanchez, M. P. Boric, and W. N. Duran, “Mechanisms of Acupuncture and herbal medicine in hypertension,” Asian Biomedicine, vol. 2, no. 4, pp. 257–274, 2008. View at Google Scholar · View at Scopus
  118. F. A. Flachskampf, J. Gallasch, O. Gefeller et al., “Randomized trial of acupuncture to lower blood pressure,” Circulation, vol. 115, no. 24, pp. 3121–3129, 2007. View at Publisher · View at Google Scholar · View at Scopus
  119. R. Zhao, L. X. Fu, J. Xiong, S. Li, and Z. L. Wang, “The effect of acupuncture therapy on essential hypertension: a systematic review of long-term effect,” Zhen Jiu Lin Chuang Za Zhi, vol. 27, no. 3, pp. 46–51, 2011. View at Google Scholar
  120. N. M. Kaplan, “Acupuncture for hypertension: can 2500 years come to an end?” Hypertension, vol. 48, no. 5, p. 815, 2006. View at Publisher · View at Google Scholar · View at Scopus
  121. Y. Li, K. Higashiura, N. Ura et al., “Effects of the Chinese medicine TSJN on insulin resistance and hypertension in fructose-fed rats,” Hypertension Research, vol. 23, no. 2, pp. 101–107, 2000. View at Google Scholar · View at Scopus
  122. H. Li, L. Liu, W. Zhao et al., “Traditional Chinese versus integrative treatment in elderly patients with isolated systolic hypertension: a multicenter, randomized, double-blind controlled trial,” Journal of Chinese Integrative Medicine, vol. 8, no. 5, pp. 410–416, 2010. View at Publisher · View at Google Scholar · View at Scopus
  123. Q. Zhou, D. K. Rowlands, Y. L. Gou, L. L. Tsang, Y. W. Chung, and H. C. Chan, “Cardiovascular protective effects of traditional Chinese medicine Bak Foong Pills in spontaneously hypertensive rats,” Biological and Pharmaceutical Bulletin, vol. 26, no. 8, pp. 1095–1099, 2003. View at Google Scholar · View at Scopus
  124. B. Wang, J. Zhang, J. Feng, H. Yin, F. Liu, and Y. Wang, “Improvement of vascular remodeling in spontaneous hypertensive rats with traditional Chinese medicine,” Clinical and Experimental Hypertension, vol. 29, no. 5, pp. 345–355, 2007. View at Publisher · View at Google Scholar · View at Scopus
  125. B. Wang, J. Zhang, J. Feng, H. Yin, F. Liu, and Y. Wang, “Effect of traditional Chinese medicine Qin-Dan-Jiang-Ya-Tang on remodeled vascular phenotype and osteopontin in spontaneous hypertensive rats,” Journal of Ethnopharmacology, vol. 110, no. 1, pp. 176–182, 2007. View at Publisher · View at Google Scholar · View at Scopus
  126. P. Ye, C. Wu, L. Sheng, and H. Li, “Potential protective effect of long-term therapy with Xuezhikang on left ventricular diastolic function in patients with essential hypertension,” Journal of Alternative and Complementary Medicine, vol. 15, no. 7, pp. 719–725, 2009. View at Publisher · View at Google Scholar · View at Scopus
  127. X. J. Xiong and J. Wang, “TCM understanding of hypertension and the control strategies by classic formulas,” Zhong Yi Za Zhi, vol. 52, no. 23, pp. 1985–1989, 2011. View at Google Scholar
  128. L. Fu, Z. X. Mao, J. Wang, T. R. Zheng, and S. L. Wang, “Effects of Song ling xue mai kang capsule on ambulatory blood pressure in treatment of essential hypertension: a single-blind randomized controlled trial,” Zhong Xi Yi Jie He Xue Bao, vol. 7, no. 6, pp. 509–513, 2009. View at Google Scholar
  129. J. Wang, X. C. Yang, B. Feng et al., “Is Yangxue Qingnao Granule combined with antihypertensive drugs, a new integrative medicine therapy, more effective than antihypertensive therapy alone in treating essential hypertension?” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 540613, 8 pages, 2013. View at Publisher · View at Google Scholar
  130. J. Wang and X. J. Xiong, “Outcome measures of Chinese herbal medicine for hypertension: an overview of systematic reviews,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 697237, 7 pages, 2012. View at Publisher · View at Google Scholar
  131. H. Xu and K. Chen, “Making evidence-based decisions in the clinical practice of integrative medicine,” Chinese Journal of Integrative Medicine, vol. 16, no. 6, pp. 483–485, 2010. View at Publisher · View at Google Scholar · View at Scopus
  132. E. Braunwald, “The rise of cardiovascular medicine,” European Heart Journal, vol. 33, no. 7, pp. 838–845, 2012. View at Publisher · View at Google Scholar · View at Scopus
  133. N. J. White, “Qinghaosu (artemisinin): the price of success,” Science, vol. 320, no. 5874, pp. 330–334, 2008. View at Publisher · View at Google Scholar · View at Scopus
  134. L. S. Liu, M. Q. Chen, G. Y. Zeng, and B. F. Zhou, “A forty-year study on hypertension,” Zhongguo Yi Xue Ke Xue Yuan Xue Bao, vol. 24, no. 4, pp. 401–408, 2002. View at Google Scholar · View at Scopus
  135. J. Li, C. Lu, M. Jiang et al., “Traditional Chinese medicine-based network pharmacology could lead to new multicompound drug discovery,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 149762, 11 pages, 2012. View at Publisher · View at Google Scholar